Tag: Insulin pumps
Medtronic to split off diabetes biz
May 21, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced it intends to separate its diabetes business, which represented 8% of revenue and 4% of segment operating profit in fiscal year 2025, into a new standalone company.
The new diabetes company will be a leading, scaled direct-to-consumer diabetes business uniquely positioned to commercialize a complete intensive insulin management ecosystem, Medtronic says.
"This marks a significant milestone in driving both Medtronic and the diabetes...
AdaptHealth works on diabetes, as sleep & oxygen make gains
March 1, 2024Theresa Flaherty, Managing Editor
PLYMOUTH MEETING, Pa. - Diabetes revenue for the fourth quarter of 2023 was down 3.8% against the prior year, driven in part by compression on insulin pumps, but AdaptHealth execs say they plan a big push to boost that part of the business in 2024.
Pump revenue in 2022 was about $160 million, and the company expected revenue of about $120 million in 2023.
“We came right in line with that expectation,” said Jason Clemens, CFO, during a recent call to discuss the company’s...
Tandem study shows great improvement for high A1c
April 18, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...
When it comes to technology, sometimes the journey is the point
December 15, 2022Theresa Flaherty, Managing Editor
I’m on information overload this week and it’s only Wednesday. And it’s technology information that I’m being inundated with. It’s exhausting.
Take work. We are switching to new laptops. This is a good thing. But in the lead up to the big switch, I had to start backing up my files differently (In the air! Somewhere!). Now, I’m not a Luddite, by any means, but some concepts are a tad bit harder for me to wrap my mind around. I have a perfectly serviceable...
DMS looks beyond strips
October 28, 2019Theresa Flaherty, Managing Editor
NEW ORLEANS -With the national mail-order program for diabetes testing supplies drastically changing the marketplace, provider Cynthia Pazos made a deliberate shift toward insulin pumps and other advanced diabetes therapies in 2016—and hasn't looked back.
“The way we conduct business—the high quality, high-touch service we give—was more conducive to being able to service patients who use insulin pumps than it was to service patients using test strips,” said Pazos,...
PE firm seeks to leverage technology in diabetes market
July 3, 2019Theresa Flaherty, Managing Editor
LOS ANGELES - With its recent acquisition of Mini Pharmacy, Angeles Equity Partners has a platform to serve a growing diabetes population, says a spokesman for the private equity firm.Mini, which was launched in 1980 and has been led by the Fox family, specializes in diabetes supplies, insulin pumps and continuous glucose monitors, and also offers enteral nutrition and disposable medical supplies, primarily to the California market.“Mini has a great reputation in the market and is well known...
Tandem targets Australasia
April 25, 2018Theresa Flaherty, Managing Editor
SAN DIEGO - Medical Device maker Tandem Diabetes Care has inked distribution agreements with Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS) to distribute Tandem's t:slim X2 Insulin Pump in Australia and New Zealand, respectively. “Partnering with key international distributors furthers our mission to expand available insulin pump choices for people with diabetes worldwide,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care....
Insulet: 'We are well on our way'
February 22, 2018HME News Staff
BILLERICA, Mass. - Insulet Corp. reported revenue of $130.5 million for the fourth quarter of 2017, an increase of 26% compared to the same period in 2016. U.S. revenue from the Omnipod was $76.5 million, an increase of 21%. Full-year revenue was $463.8 million and U.S. revenue from the Omnipod was $271.6 million. Among Insulet's highlights for 2017: It received Medicare coverage under the prescription drug benefit for the Omnipod, paving the way to capturing an additional one-third of the U.S. market;...
Insulin pump decision could have chilling effect
May 27, 2016Theresa Flaherty, Managing Editor
YARMOUTH, Maine - UnitedHealthcare's recent decision to only cover insulin pumps provided by Medtronic is bad news all around, say industry stakeholders.In May, the insurance giant announced it had inked an agreement with the medical device maker to serve as exclusive provider of insulin pumps to its members.“To take away beneficiary choice over economics is not a good thing,” said Dan Gooch, owner of Pal-Med in Columbia, S.C., which offers pumps from Medtronic, Animas and Tandem. “I...
Study outlines access issues for insulin pumps
March 20, 2015Theresa Flaherty, Managing Editor
CHICAGO - A recent survey by the American Association of Diabetes Educators found that beneficiary access to insulin pumps and supplies in Round 1 bid areas is “a little worse than expected.”
“From our perspective, we figured there'd be some element of access issues, but it was a little worse than what we expected,” said James Specker, director of federal and state advocacy for the AADE.
Insulin pumps and supplies were included in a new infusion category as part...